Delivery Order SPE2DB20D1100-SPE2DB25FE1BL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,729.40. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 31, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This competitively awarded, non-set-aside contract has a ceiling value of $5,061.63 and an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack units) with a ceiling value of $2,704.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.50 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This $4,480.59 firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.15 mg auto-injector 2-packs with a ceiling value of $10,174.38 and firm fixed pricing. The order, which is not a set-aside contract, is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $18,278.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1BLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Epinephrine 0.15 mg auto-injectors in a two-pack configuration. This contract, valued at $11,352.44, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is a child contract issued under the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026 that enables the company to furnish a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its critical role as a vendor for the Defense Health Agency and other government healthcare systems. The company's qualification through open competition and track record of delivering diverse pharmaceutical commodities—ranging from specialty medications and vaccines to medical devices and auto-injectors—reflects its capability to meet federal medical procurement standards. This delivery order for epinephrine auto-injectors supports emergency medical preparedness within the military healthcare supply chain and is scheduled for completion by September 26, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 9/25/25 |